ATHENS MEDICAL SOCIETY

ATTIKON University General Hospital, ATHENS

Presentations of Athena International Conference 2019

Tuesday 19-11-2019

       

09.00 - 09.15 Welcome and introductions

G. Dimopoulos (Greece)

(view presentation)

09.15 - 11.00

sCAP in the ICU
Chairs :A. Armaganidis (Greece) - A. Koutsoukou (Greece)


       

09.15 - 09.30 Community healthcare associated infections: more similar to hospital-acquired?

P. Povoa(Portugal)

(view presentation)

       

09.30 - 09.45 Short Course Antibiotic Treatment for Pneumonia:Is It Safe?

M. Kollef(USA)

(view presentation)

       

09.45 - 10.00 VAE vs VAP: the central role of hypoxemia

S. Nseir(France)

(view presentation)

       

10.00 - 10.15 sAP in immunocompromised patients

S. Metallidis(Greece)

(view presentation)

       

10.00 - 10.15 Burden and unmet needs for CAP

J. Rello(Spain)

       

10.30 - 11.00 Discussion


11.00 - 11.30

Satellite Lecture (HAMILTON MEDICAL)
Chair :A. Koutsoukou


       

11.00 - 11.30 Open lung approach 2.0

G. A. Iotti (Italy)

(view presentation)

11.30 - 12.00

Satellite Lecture (3M)
Chair :D. Matthaiou (Greece)


       

11.30 - 12.00 CRBSI’s prevention. Health Economics and Clinical Outcomes

G. Theodorakopoulos (Greece)

(view presentation)

       

12.00 - 13.00 Break


Attractive issues on infectiohns in the ICU
Chairs :A. Komnos (Greece) - E. Antoniadou (Greece)


       

13.00 - 13.15 Prolonged infusion of antibiotics: When and how?

J. De Waele(Belgium)

(view presentation)

       

13.15 - 13.30 Probiotics/Synbiotics for ICU Patients: Are They Still on Board?

M. Akova (Turkey)

(view presentation)

       

13.30 - 13.45 Rapid Microbiologic Diagnostics: Can They Improve Clinical Outcomes?

M. Kollef(USA)

(view presentation)

       

13.45 - 14.00 C difficile antitoxin and prevention of infection

M. Wilcox(UK)

(view presentation)

       

14.00 - 14.15 CRE in IA sepsis - How big is the problem?

C. Eckmann(Germany)

(view presentation)

       

14.15 - 14.30 Long-acting antibiotics: the future ?

F. Menichetti(Italy)

(view presentation)

       

14.30 - 15.00 Discussion


15.00 - 17.00

Next Generation Antibiotics
Chairs :E. Zakynthinos (Greece) - C. Gogos (Greece)


       

15.00 - 15.15 Omadacycline

Y. Carmeli(Israel)

(view presentation)

       

15.15 - 15.30 Eravacycline

D. Nicolau(USA)

(view presentation)

       

15.30 - 15.45 Lefamulin

M. Bassetti (Italy)

       

15.45 - 16.00 Meropenem-Varbobactam

E. Giamarellos(Greece)

(view presentation)

       

16.00 - 16.15 Aztreonam Avibactam

M. Akova(Turkey)

(view presentation)

       

16.15 - 16.30 Imipenem-Relebactam

J. F. Timsit(France)

(view presentation)

       

16.30 - 17.00 Discussion

       

17.00 - 17.30 Break


17.30 - 19.00

Satellite Symposium (PFIZER) The role of ceftazidime/avibactam in the treatment of resistant Gram-negative infections
Chairs : G. Daikos (Greece) - H. Giamarellou (Greece)


       

17.30 - 17.45 Mechanisms of resistance in Pseudomonas and Klebsiella: The role of ceftazidime avibactam

G. Daikos(Greece)

       

17.45 - 18.00 PK/PD in critically ill patients: Pharmacology of a β-Lactam/β-Lactamase inhibitor

D. Nicolau (USA)

(view presentation)

       

18.00 - 18.15 Greek experience with ceftazidime-avibactam

H. Giamarellou(Greece)

(view presentation)

       

18.15 - 18.30 Worldwide experience with ceftazidime-avibactam

M. Bassetti(Italy)

       

18.30 - 19.00 Discussion


19.00 - 19.30

Award Ceremony dedicated to Prof. Helen Giamarellou
Chair : G. Dimopoulos (Greece)


       

19.00 - 19.30 A fight of 50 years against infections

H. Giamarellou(Greece)

(view presentation)

Wednesday 20-11-2019


09.00 - 11.00

Lessons from the management of difficult infections in the ICU
Chairs : J. Pnevmatikos (Greece) - K. Arvaniti (Greece)


       

09.00 - 09.15 Rapid diagnosis of respiratory infections

S. Metallidis (Greece)

(view presentation)

       

09.15 - 09.30 MDR Pseudomonas infections: Aminoglycosides and colistin do not improve outcome?

Y. Carmeli (Israel)

(view presentation)

       

09.30 - 09.45 Do aerolized antibiotics still have a role for VAP

J. Rello(Spain)

       

09.45 - 10.00 Should procalcitonin use be mandatory for determining antibiotic duration?

P. Povoa (Portugal)

(view presentation)

       

10.00 - 10.15 Minocycline and rifampin against MDR

M. Bassetti (Italy)

       

10.15 - 10.30 Why immunocompromised patients fail to respond to antifungals

O. Cornely (Germany)

(view presentation)

       

11.40 - 12.00 Discussion


11.00 - 12.00

Satellite Symposium (NORMA) Nebulized antibiotics: The right position
Chair : G. Poulakou (Greece)


       

11.00 - 11.20 How to reduce Bacterial Resistance using inhaled antibiotics

L. Palmer (USA)

(view presentation)

       

11.20 - 11.40 Nebulized colistin: When and why?

J. Rello (Spain)

       

11.40 - 12.00 Discussion


12.00 - 12.30

State of the Art Lecture
Chairs : H. Sambatakou (Greece) - P. Gargalianos (Greece)


       

12.00 - 12.30 Bacteriome and mycobiome interactions: Effect on health and disease

M. Ghannoum (USA)

(view presentation)

       

12.30 - 13.30 Break


13.30 - 15.30

Towards the future
Chairs : E. Zakynthinos (Greece) - G. Vlachogianni (Greece)


       

13.30 - 13.45 e-learning in infection prevention and control

D. Vogelaers(Belgium)

       

12.00 - 12.30 Lasers and Nanoparticles into biofilms

M. Ghannoum (USA)

(view presentation)

       

14.00 - 14.15 The importance of viruses infections in ICU patients

J. Chastre(France)

(view presentation)

       

14.15 - 14.30 Sepsis: Right time for antibiotic therapy?

T. Calandra(Switzerland)

       

14.30 - 14.45 Bacteriophages for antimicrobial therapy

J. Van der Meer(The Netherlands)

(view presentation)

       

14.45 - 15.00 Siderophore - Antibiotic conjugates

D. Nicolau(USA)

(view presentation)

       

15.00 - 15.30 Discussion


15.30 - 17.30

Surgical infections
Chairs : V. Koulouras (Greece) - I. Koutelidakis (Greece)


       

15.30 - 15.45 Severe Acute Pancreatitis: when to use

J. De Waele(Belgium)

(view presentation)

       

15.45 - 16.00 Necrotizing fasciitis

P. Montravers(France)

(view presentation)

       

16.00 - 16.15 Source control in intraabdominal sepsis - Tips and tricks for non-surgeons

C. Eckmann(Germany)

(view presentation)

       

16.15 - 16.30 C. difficile infections: New options for treatment

M. Wilcox(UK)

(view presentation)

       

16.30 - 16.45 Cardiovascular implantable device infections

N. Petrosillo(Italy)

(view presentation)

       

16.45 - 17.00 Chlorhexidine For Everything?

M. Niederman(USA)

(view presentation)

       

17.00 - 17.30 Discussion

       

17.30 - 18.00 Break


18.00 - 18.30

Satellite Lecture (PFIZER)
Chair : A. Koutsoukou


       

18.00 - 18.20 Treating Aspergillosis in the ICU: The role of Isavuconazole

G. Dimopoulos (Greece)

(view presentation)

       

18.20 - 18.30 Discussion


18.30 - 19.30

Satellite Symposium (BIOMERIEUX) The use of syndromic testing to improve antibiotic use in patients with severe pneumonia
Chair : P.F. Laterre (Belgium)


       

18.30 - 18.50 Applying Molecular Syndromic Testing alongside biomarkers: the PROGRESS paradigm

E. Giamarellos (Greece)

(view presentation)

       

18.50 - 19.10 Using syndromic testing to challenge the paradigm of antibiotic use in patients with severe pneumonia

P. F. Laterre (Belgium)

       

19.10 - 19.30 Discussion


19.30 - 20.00

State of the art Lecture
Chair :E. Giamarellos (Greece)


       

19.30 - 20.00 Modulating the microbiota in critically ill patients (antibiotics, SDD, feacal transplantation)

J. Van der Meer (The Netherlands)

(view presentation)

Thursday 21-11-2019


09.00 - 11.00

Fungal infections
Chairs :S. Orfanos (Greece) - D. Kofteridis (Greece)


       

09.00 - 09.15 Fungal Biofilms

M. Ghannoum (USA)

(view presentation)

       

09.15 - 09.30 Candida auris: A new enemy?

T. Calandra (Switzerland)

       

09.30 - 09.45 Echinocandins: Mechanisms of resistance

J. A. Paiva (Portugal)

       

09.45 - 10.00 New antifungals (APX001, F91318, Am Cochleate, SCY078, VL2394)

O. Cornely (Germany)

       

10.00 - 10.15 Rare cases of Aspergillosis (tracheobronchitis, pericardial, celebral) in the ICU

D. Vogelaers (Belgium)

       

10.15 - 10.30 Rezafungin

H. Sambatakou

(view presentation)

       

10.30 - 11.00 Discussion


11.00 - 11.30

State of the art Lecture
Chair : T. Vassilakopoulos (Greece)


       

11.00 - 11.30 Can we apply SSC guidelines in every single ICU in the world? The view from LMIC

J. L. Vincent (Belgium)


11.30 - 13.30

How to...
Chairs : G. Baltopoulos (Greece) - A. Kotanidou (Greece)


       

11.30 - 11.45 … save Carbapenems in the ICU ?

P. Montravers (France)

(view presentation)

       

11.45 - 12.00 … manage Gram-positive resistant infections

J. Chastre (France)

(view presentation)

       

12.00 - 12.15 … treat malaria in the ICU: Challenges in management

N. Petrosillo (Italy)

(view presentation)

       

12.15 - 12.30 … optimize delivery of inhaled antibiotics in the ICU

L. Palmer (USA)

(view presentation)

       

12.30 - 12.45 … approach influenza - associated Aspergillosis

J.A. Paiva (Portugal)

       

12.45 - 13.00 … treat measles outbreaks

F. Menichetti

(view presentation)

       

13.00 - 13.30 Discussion

       

13.30 - 14.30 Break


14.30 - 15.30

Tuberculosis in the ICU
Chairs :N. Koulouris (Greece) - N. Kapravelos (Greece)


       

14.30 - 14.50 New drugs against tuberculosis

G. B. Migliori(Italy)

(view presentation)

       

14.50 - 15.10 How to treat MDR/PDR Tuberculosis

G. Sotgiu (Italy)

(view presentation)

       

15.10 - 15.30 Discussion


15.30 - 16.30

Satellite Symposium (AMOMED) Decatecholaminization in the ICU
Chair :P. Myrianthefs (Greece)


       

15.30 - 15.45 Catecholamine-toxicity in ICU patients and therapeutic alternatives in clinical practice

A. Rudiger(Switzerland)

(view presentation)

       

15.45 - 16.00 Landiolol – A new β-blocker in the ICU

W. Dabrowski(Poland)

(view presentation)

       

16.00 - 16.150 Discussion


17.00 - 17.30

Satellite Lecture (Helix²-T2Biosystems)


       

16.30 - 16.50 Volume replacement with a new balanced crystalloid solution

P. Myrianthefs(Greece)

(view presentation)

       

16.50 - 17.00 Discussion


17.00 - 17.30

Satellite Lecture (Helix²-T2Biosystems)
Chair :S. Pournaras (Greece)


       

17.00 - 17.30 Impact of the T2Bacteria and T2Candida panels on changing clinical outcomes

O. Guzman(USA)

(view presentation)

       

17.30 Closing and Remarks of the Conference

Copyright © 2019 ATHENA International Conference. Design by PlanTech